Durable complete response with a short course of streptozotocin plus doxorubicin combination in malignant metastatic insulinoma


Karatas F., Sahin S., Aytekin A., HACIOĞLU M. B., Imamoglu G., Altinbas M.

Journal of Cancer Research and Therapeutics, cilt.14, sa.5, ss.1149-1151, 2018 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 14 Sayı: 5
  • Basım Tarihi: 2018
  • Doi Numarası: 10.4103/0973-1482.188293
  • Dergi Adı: Journal of Cancer Research and Therapeutics
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1149-1151
  • Anahtar Kelimeler: Doxorubicin, durable response, insulinoma, pancreatic neuroendocrine tumors, short course, streptozotocin
  • Trakya Üniversitesi Adresli: Evet

Özet

Due to the cytotoxic effects of old chemotherapy regimens used in the islet cell tumors, capecitabine plus temozolomide combination has now become the first choice in the treatment of malignant insulinoma (MIoma). We present this case to emphasize and remind that a durable complete response in advanced stage MIoma may be achieved with a short course of streptozotocin plus doxorubicin combination.